Medhane G. Cumbay
Affiliations: | Pharmacal Sciences | Butler University, Indianapolis, IN, United States |
Google:
"Medhane Cumbay"Mean distance: 17.26 (cluster 6) | S | N | B | C | P |
Parents
Sign in to add mentor| Val J. Watts | grad student | 2004 | Purdue | |
| (Characterization of novel regulatory properties of adenylate cyclase type nine.) | ||||
| Gerry S. Oxford | post-doc | IUPUI | ||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Cumbay MG, Watts VJ. (2005) Galphaq potentiation of adenylate cyclase type 9 activity through a Ca2+/calmodulin-dependent pathway. Biochemical Pharmacology. 69: 1247-56 |
| Cumbay MG, Watts VJ. (2004) Novel regulatory properties of human type 9 adenylate cyclase. The Journal of Pharmacology and Experimental Therapeutics. 310: 108-15 |
| Marona-Lewicka D, Kurrasch-Orbaugh DM, Selken JR, et al. (2002) Re-evaluation of lisuride pharmacology: 5-hydroxytryptamine1A receptor-mediated behavioral effects overlap its other properties in rats. Psychopharmacology. 164: 93-107 |
| Neve KA, Cumbay MG, Thompson KR, et al. (2001) Modeling and mutational analysis of a putative sodium-binding pocket on the dopamine D2 receptor. Molecular Pharmacology. 60: 373-81 |
| Johnston CA, Cumbay MG, Vortherms TA, et al. (2001) Adrenergic agonists induce heterologous sensitization of adenylate cyclase in NS20Y-D(2L) cells. Febs Letters. 497: 85-9 |
| Cumbay MG, Watts VJ. (2001) Heterologous sensitization of recombinant adenylate cyclases by activation of D(2) dopamine receptors. The Journal of Pharmacology and Experimental Therapeutics. 297: 1201-9 |
| Blair JB, Kurrasch-Orbaugh D, Marona-Lewicka D, et al. (2000) Effect of ring fluorination on the pharmacology of hallucinogenic tryptamines. Journal of Medicinal Chemistry. 43: 4701-10 |
| Schutzer WE, Watts VJ, Chapman J, et al. (2000) Viral-mediated gene delivery of constitutively activated G alpha s alters vasoreactivity. Clinical and Experimental Pharmacology & Physiology. 27: 9-13 |
| Eshleman AJ, Carmolli M, Cumbay M, et al. (1999) Characteristics of drug interactions with recombinant biogenic amine transporters expressed in the same cell type. The Journal of Pharmacology and Experimental Therapeutics. 289: 877-85 |
| Watts VJ, Wiens BL, Cumbay MG, et al. (1998) Selective activation of Galphao by D2L dopamine receptors in NS20Y neuroblastoma cells. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 18: 8692-9 |